Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
Open Access
- 7 May 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 11 (5), 405-411
- https://doi.org/10.1016/j.jcf.2012.03.009
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical use of dornase alfa is associated with a slower rate of FEV1 decline in cystic fibrosisPediatric Pulmonology, 2011
- Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpointJournal of Cystic Fibrosis, 2010
- Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic FibrosisThe Journal of Pediatrics, 2007
- Predictors of deterioration of lung function in cystic fibrosis*Pediatric Pulmonology, 2002
- Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patientsStatistics in Medicine, 2002
- Gender differences in cystic fibrosis: Pseudomonas aeruginosa infectionJournal of Clinical Epidemiology, 1995
- Correlation between Genotype and Phenotype in Patients with Cystic FibrosisThe New England Journal of Medicine, 1993
- Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patientsJournal of Clinical Epidemiology, 1990
- Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosaThe Journal of Pediatrics, 1990
- Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbationThe Lancet, 1990